Focus research 2022 DIAD team
Focus research 2022 DIAD team Theranostic radiolabeled molecules and the concept of optimal exposure We are developing the concept of optimal plasma exposure, which is well known for ‘classical’ drugs, in the context of vectorized internal radiotherapy and in...
Impact of co-administration of two amino acid solutions on the elimination and adverse effects of 177Lu-Dotatate
Impact of co-administration of two amino acid solutions on the elimination and adverse effects of 177Lu-Dotatate 177Lu-Dotatate Somatostatin analogs population pharmacokinetic analysis relationship pharmacokinetic/pharmacodynamics neuroendocrin tumor theranostic...
Role of genetic mutations in trabectedin liver toxicity.
Role of genetic mutations in trabectedin liver toxicity. ABC transporters advanced soft tissue sarcomas CYP450 hepatotoxicity next-generation sequencing trabectedine Maud Mailard Fabienne Thomas – tean : DIAD : Individualisation of cancer drug doses Trabectedin...
The value of screening for DPD activity in all patients treated with fluoropyrimidines.
The value of screening for DPD activity in all patients treated with fluoropyrimidines. 5-Fluorouracile breast cancer capecitabine DPD deficiency Maud MAILLARD – t team DIAD Dose-Individualization of Anti-cancer Drugs, CRCT Fluoropyrimidines (mainly...
